CBA
Coastal Bridge Advisors’s Processa Pharmaceuticals PCSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-64,956
| Closed | -$21.7K | – | 182 |
|
|
2023
Q4 | $21.7K | Buy |
64,956
+12,456
| +24% | +$4.17K | 0.01% | 172 |
|
|
2023
Q3 | $13.1K | Hold |
52,500
| – | – | ﹤0.01% | 170 |
|
|
2023
Q2 | $26.1K | Hold |
52,500
| – | – | 0.01% | 164 |
|
|
2023
Q1 | $26.3K | Hold |
52,500
| – | – | 0.01% | 166 |
|
|
2022
Q4 | $57.8K | Hold |
52,500
| – | – | 0.02% | 163 |
|
|
2022
Q3 | $119K | Hold |
52,500
| – | – | 0.03% | 162 |
|
|
2022
Q2 | $148K | Buy |
52,500
+20,000
| +62% | +$56.4K | 0.05% | 142 |
|
|
2022
Q1 | $98K | Hold |
32,500
| – | – | 0.02% | 162 |
|
|
2021
Q4 | $159K | Buy |
32,500
+5,000
| +18% | +$24.5K | 0.03% | 189 |
|
|
2021
Q3 | $236K | Hold |
27,500
| – | – | 0.05% | 123 |
|
|
2021
Q2 | $225K | Buy |
27,500
+7,500
| +38% | +$61.4K | 0.05% | 127 |
|
|
2021
Q1 | $218K | Buy |
+20,000
| New | +$218K | 0.04% | 129 |
|